Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Medical Legal
GlaxoSmithKline (GSK) Settlement and Corporate Integrity Agreement
The Department of Justice (DOJ) announced its largest health care fraud settlement in U.S. history: $3 Billion from…
Abbott Settlement and Corporate Integrity Agreement
Continuing the recent trend of large legal settlements with pharmaceutical companies, the Department of Justice (DOJ) this week…
Stryker Biotech: Case Dismissed Charges Dropped
Over the past few years, there has been no shortage of legal cases brought by federal and state prosecutors against drug and…
DOJ Failed Case against GSK Staff Lawyer Lauren Stevens: Lessons Learned
In November 2010, the Department of Justice (DOJ) issued a press release discussing a six-count indictment against Lauren Stevens…
CMS and OMB Announce New Fraud Measures
In 2010, the President announced three goals for cutting improper payments in federal health programs by 2012: reducing overall…
Sorrell vs. IMS Health: FDA’s Ban on Truthful Off Label Promotion May be…
A recent panel of health lawyers discussed the Supreme Court decision in IMS v. Sorrell and further assessed the impact of the…
The Park Doctrine and FDCA Violations: Holding Corporate Executives…
Over the past several months, the life sciences industry has been discussing a recent development in law enforcement: the…
DOJ Outlines Balance between Encouragement and Enforcement in Healthcare…
With the announcement of a recent settlement between the Department of Justice (DOJ) and drugmaker GlaxoSmithKline for the drug…
Par Pharmaceuticals vs. FDA Calling for Truthful Speech vs. FDA Approved
Last June, the United States Supreme Court, in a landmark decision, invalidated a Vermont law, which tried to restrict commercial…
Whistle Blower Case May Raise the Bar for Evidence
Recently the U.S. Court of Appeals for the First Circuit issued an opinion that has the potential to significantly change the…